Firms
Theme

UNFI

United Natural Foods Inc · NYSE

News

3 latest

Zacks Investment Research

Why Is United Natural (UNFI) Down 2.3% Since Last Earnings Report?

United Natural Foods reported Q4 fiscal 2026 results beating both earnings and revenue estimates, with adjusted EPS of 69 cents versus 62 cents consensus and net sales of $7.64 billion topping expectations. The company achieved margin improvements through network optimization and cost-saving initiatives, with adjusted EBITDA rising 48.3% to $172 million.

Zacks Investment Research

United Natural Foods' Lean Rollout Reaches 44 DCs: What's Next?

United Natural Foods (UNFI) has completed the initial deployment of Lean daily management across 44 distribution centers by the end of fiscal 2026. The initiative has yielded measurable improvements in key operational metrics: fill rates improved 2 points, on-time delivery advanced 5 points, and throughput rose 12 points year-over-year in Q4 fiscal 2026. The company plans to advance to Lean 2.0 to deepen adoption and further improve service and productivity metrics.

Mentions UNFI

Zacks Investment Research

Why Is Hain Celestial (HAIN) Down 9.1% Since Last Earnings Report?

Hain Celestial reported Q4 fiscal 2026 results with an adjusted loss of 5 cents per share, wider than consensus estimates, though net sales beat expectations at $263.1 million. The company is selling its International business to AURELIUS for approximately $323.2 million to reduce debt and focus on its North American operations.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $UNFI · 0 threads

Sign in to post on $UNFI

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev